A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL GROUP, 12-MONTH SAFETY AND EFFICACY TRIAL OF LEUCO-METHYLTHIONINIUM BIS(HYDROMETHANESULFONATE) IN SUBJECTS WITH BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA (BVFTD)
- Registry ID
- TRX-237-007
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Study type
- INTERVENTIONAL
- Sponsor
- TAURX THERAPEUTICS LTD
- Start date
- 2013-05-30
- Completion date
- 2016-02-10
- Last update
- 2013-05-10
Conditions
- BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA (BVFTD)
View on source registry